Patient Registry Software Market
Meticulous
Research® –leading global market research
company published a research report titled “PatientRegistry Software Market by Type (Diabetes, Cancer, Rare Diseases, CVD,
Orthopedic, Drugs, Device), Delivery (On premise, Cloud), Functionality (PHM,
HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User –
Global Forecast to 2023”.
According to this latest
publication from Meticulous Research®, the global patient registry
software market is expected to grow at a CAGR of 11.0% from 2018 to 2023 to
reach USD 1.4 billion by 2023, driven by factors such as continued pressure to
curtail rising healthcare costs, growing demand to improve care quality,
increasing adoption of EHRs and improving health IT infrastructure, growing
application of patient registry data in post-marketing surveillance, and
increase in the support from government for value-based care and adoption of
patient registries. Moreover, growing emphasis on population health management
and proliferating accountable care organizations (ACO), emergence of
cloud-based patient registry solutions, and shifting focus towards
Patient-Powered Research Networks (PPRNs) offer significant growth
opportunities for the market players during the forecast period.
The patient registry
software market study presents historical market data in terms of value (2016
and 2017), estimated current data (2018), and forecasts for 2023 by registry
type (disease registry, health services registry, and product registry),
software (standalone, integrated), pricing model (subscription, ownership),
deployment model (on premise, web &cloud), database type (commercial,
public), functionality (population health management, patient care management,
health information exchange, point-of-care, product outcome evaluation, medical
research & clinical studies), and end user (government organizations &
third-party administrators, hospitals and medical practices, private payers,
pharmaceutical, biotechnology, and medical device companies, research centers).
The study also evaluates industry competitors and analyzes the market at a
regional and country level.
Browse
in-depth Report on https://www.meticulousresearch.com/product/patient-registry-software-market/
With the rising
prevalence of chronic disease conditions such as diabetes, cardiovascular
diseases and asthma, there is a growing need for chronic disease registries
that can help manage patients proactively. Moreover, increasing number of
initiatives are being taken across the globe to build rare disease patient
registries to gain a better understanding of rare diseases. Such efforts
contribute to the largest share of patient registry software for disease
registries.
Standalone software
comprised the major market share in 2017 as these are usually less complex,
dedicated, cost-effective and simpler to setup than integrated systems.
However, with the trend towards integrated care, healthcare organizations would
increasingly consider integrating the use of registries into clinicians’
workflows at the point-of-care, and interfacing registries with EHRs. This in
turn will drive the integrated patient registry software market at the
highest CAGR during the forecast period.
In 2017, on premise
solutions captured a major share owing to concerns related to patient data
confidentiality and security on remotely managed servers. However, cloud-based
solutions are anticipated to grow at a lucrative rate for their real-time data
analysis, easy accessibility, flexibility, scalability, and cost-effectiveness.
Request
Sample Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=4227
Application of patient
registry software for population health management (PHM) held a significant
market share in 2017 and is also expected to continue to grow at the fastest
CAGR owing to government initiatives for encouraging value-based care and PHM
programs.
Government organizations
and TPAs are currently the major end users of patient registry software.
However, hospitals and medical practices are expected to be in the spotlight
during the forecast period.
This research report
analyzes major geographies and provides a comprehensive analysis of North
America (U.S. and Canada), Europe (Germany, U.K., France, Italy, Spain, and
RoE), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the
Middle East & Africa. North America captured a significant share in 2017
and is expected to register the highest CAGR during the forecast period mainly
due to presence of major Health IT companies in the U.S., advanced healthcare
and health IT infrastructure, rising demand for structured information by
healthcare stakeholders, increasing need to curtail healthcare costs,
implementation of the ACA in the U.S., and rising focus on population health
management. In addition, significant growth in the number of EHRs, Accountable
Care Organizations (ACOs) and health information exchange (HIEs) further
supports the greater adoption and fastest growth in this region.

Speak To Analyst: https://www.meticulousresearch.com/speak-to-analyst/?cp_id=4227
The patient registry
software market is highly competitive and fragmented with the presence of some
large well-established IT companies and several small and emerging vendors.
Some of the key players contributing to the growth of the patient registry
software market include Phytel, Inc. (An IBM Corporation Company) (U.S.),
Quintiles IMS Holdings, Inc. (U.S.), Liaison Technologies. (U.S.), ImageTrend,
Inc. (U.S.), FIGmd, Inc. (U.S.), McKesson Corporation (U.S.) (Change
Healthcare), CECity.com Inc. (U.S.) (A Premier, Inc. Company) , Dacima
Software Inc. (U.S.), Global Vision Technologies, Inc. (U.S.), ifa Systems AG,
(Germany), Syneos Health (U.S.), M2S, Inc. (U.S.), Optum, Inc (A part of
UnitedHealth Group Inc) (U.S.), EVADO Pty. Ltd. (Australia), and Velos, Inc.
(U.S.) among several others. In the recent past, these companies significantly
focused on entering into agreements, partnerships, strategic alliances, and
collaborations to expand their product and service offerings, strengthen their
global footprint, and augment their market shares.
About Meticulous Research®
MeticulousResearch® is founded in 2010 and incorporated
as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company
under the Companies Act, 1956. Since its incorporation, the company has become
the leading provider of premium market intelligence in North America, Europe,
Asia-Pacific, Latin America, and Middle East & Africa.
Contact Us:
Viren Shrivastava
Viren Shrivastava
AVP-
Global Sales and Marketing
Meticulous
Research®
Tel:
+1-646-781-8004
Email:
viren@meticulousresearch.com
Comments
Post a Comment